It’s not uncommon for high blood pressure and AFib to both be present in the same person. In fact, one medical study found the following:
Enter your email to receive our newsletter and to stay updated.
Awareness is your first defense against AFib’s silent threat. While sporadic checks might miss the mark, regular ECG and blood pressure monitoring offers a more comprehensive view of your heart’s health. This not only allows your doctor to detect early risks of AFib and preempt serious complications but also optimizes treatment plans and tracks post-surgery recovery leading to less emergency visits.
Monitoring blood pressure and ECG at home plays a crucial role in stroke prevention. It empowers individuals to identify irregular heart rhythms early, allowing for prompt medical intervention and ultimately reducing the risk of stroke.
Spotting AFib signs early from home can prevent more serious complications with timely and effective interventions.
Reliable and consistent data from home assists in tailoring optimal treatment strategies.
Home monitoring delivers definitive readings so you’ll know if there’s a heart rhythm irregularity, reducing the stress of uncertainty.
Helps with monitoring progress after surgical interventions, ensuring care that goes beyond the doctor’s officce.
Traditional ECGs rely on wired electrodes to track heart signals. OMRON advances this with portable devices featuring built-in sensors. Placing your fingers on the sensors facilitate swift heart monitoring; the companion app instantly captures and interprets the ECG results, so there’s no second guessing.
Electrocardiogram recording is an effective test to check the condition of the heart, but it does not express all changes and symptoms of the heart. If the analysis results of your records show "normal sinus rhythm" but you still have symptoms, or if "Unable to classify" or "Unable to analyze" is repeatedly displayed, please consult your doctor. Self-judgment and treatment based on analysis results is dangerous. Do not judge the recorded results (electrocardiogram waveform) or the messages displayed by analyzing them on your own; consult your doctor. Self-judgment based on analysis results may lead to worsening of symptoms.
Grounded in extensive user data, our devices set unparalleled benchmarks in accuracy.
Our devices are designed so it’s quick to operate and devoid of any confusing intricacies.
Built to last, you get accurate readings, time after time.
OMRON’s integrated ecosystem consolidates various health metrics, offering a bird’s eye view of patient health.
In 2020, OMRON’s Complete emerged as the pioneering BP monitor, seamlessly integrating ECG capabilities. Rigorous clinical testing affirmed its precision in distinguishing sinus rhythm from AF during BP measurements.
In a 2019-2020 initiative, Kyoto University partnered with OMRON, utilizing the Complete for AFib screenings in older populations. Alongside screenings, educational lectures were provided, enhancing awareness. Their research compared the life outcomes between those treated with direct-acting oral anticoagulants (DOACs) for AFib and those untreated. Results revealed a concerning number of undiagnosed AFib cases. Notably, with proper anticoagulant treatment, the study showcased a significant reduction in potential strokes throughout patients’ lives.
KardiaMobile is a convenient way to monitor for AFib recurrence after cardiac surgery.
KardiaMobile smartphone-based ECG monitors added to the 2017 consensus guidelines for patients post-ablation.
Self-monitoring with KardiaMobile improves AFib detection and self-reported quality of life.
OMRON connect is a free companion app that makes it easy to record, view and sync personal health data from your OMRON devices, all in one place. You can set individual targets, monitor progress overtime, or even share results with your doctor such as blood pressure, weight, and track your progress over time.
1. NHS. Home. Health A to Z. Atrial fibrillation. Available at: https://www.nhs.uk/conditions/atrial-fibrillation/. Accessed May 2023
2. European Society of Cardiology. The ESC. ESC Press Office. Press releases. Available at: https: // www.escardio.org/The-ESC/Press-Office/Press releases/ Atrial-fibrillation-set-to-affect-more-than-14-million-over-65s-in-the-EU-by 2060#:~:text=Atrial%20fibrillation%20is%20the
%20most,are%20 caused%20 by%20atrial%20fibrillation. Accessed May 2023.
https://www.hopkinsmedicine.org/health/
conditions-and-diseases/atrial-fibrillation#:~:text=With%20Afib%2C%20
electrical%20impulses%20fire,blood%20
and%20pump%20blood%2Onormally.
3. Stark, L., et al. (2017). Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circulation research, [online] 120(9), pp. 1501-1517. doi:https://doi.org/10.1161/CIRCRESAHA
.117.309732.
4. Lloyd-Jones DM et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study, Circulation. 2004 Aug 31;110(9): 1042-6.
5. NHS. Home. Health A to Z. Atrial fibrillation. Available at: https://www.nhs.uk/conditions/atrial-fibrillation/complications/. Accessed May 2023.
6. Verdecchia, P., et al. (2018). Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and
Clinical Studies. Circulation research, [online] 122(2),
pp.352-3https://doi.org/10.1161/CIRCRESAHA.117.311402.
7.https://www.hopkinsmedicine.org/health/
conditions-and-diseases/atrial-fibrillation#:-:text=With%20Afib%2C%20
electrical%20impulses%20fire, blood %20 and %20 pump %20blood %2Onormally.
We wish to caution job seekers that OMRON does not authorize external parties to conduct employment drives or extend offers of employment on its behalf. OMRON does not make unsolicited offers of employment and ask for any financial commitment from a candidate as a pre-employment requirement. Further, Omron does not contact prospective candidates through WhatsApp, Telegram or any other instant messaging apps or social media websites. Please be aware that if you receive or see any request of this regard, it might be coming from parties or persons that are not affiliated to OMRON in any way.
OMRON bears no responsibility for the consequences of the actions either from the fraudsters or the victims.